You are here

Article info

Article menu
Download PDFPDF
Editorials
Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good

Authors

  1. Correspondence to Athol U Wells, C/O Emmanuel Kaye Building Manresa Road, Chelsea, London SW3 6LR, UK; athol.wells{at}rbht.nhs.uk
View Full Text

Citation

Wells AU, Behr J, Costabel U, et al
Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good
Thorax 2012;67:938-940.

Publication history

  • Received August 16, 2012
  • Accepted August 17, 2012
  • First published October 9, 2012.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions